« Back
Home /
Refanezumab Biosimilar（Anti-Siglec-4a / MAG Reference Antibody）

Refanezumab Biosimilar（Anti-Siglec-4a / MAG Reference Antibody）

Item no.	DCC-A495-1mg
Manufacturer	DCChemicals
CASRN	1233953-61-1
Amount	1 mg
Quantity options	100 mg 10 mg 1 mg 5 mg
Category	Neuroscience Molecular Targets for Neuroscience
Specific against	other
Available
Manufacturer - Applications	Refanezumab (GSK249320) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. Refanezumab can cross the blood-brain barrier (BBB) in animal stroke models. Refanezumab has the potential for the enhancement of recovery of function poststroke.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer